Skip to main content

Is the Healthcare Sector Still a Good Investing Opportunity?

Author:
Publish date:
Video Duration:
0

So, how should investors approach healthcare after a headline like a judge in Oklahoma ruling against Johnson & Johnson (JNJ) - Get Johnson & Johnson Report in an opioid case?

J&J was ordered to pay $572 million to the state of Oklahoma. However, the sum was much less than the $17 billion in penalties originally sought by the state.

Karen Davies, senior vice president, and managing director with Huntington Commercial Bank sat down with TheStreet to talk about M&A, the healthcare sector and her thoughts on a possible economic downturn. 

"Obviously it's newsworthy and apparently, Johnson & Johnson is sort of the first one to sort of pay in this risk sector. I do believe from a healthcare standpoint, there are still plenty of opportunistic areas for investment. We saw it last year with heavy hospital consolidation, bringing the cost down for those large operators. We've seen big pharma deals getting done, as of recent Celgene, and we've seen a lot of transactions getting done where pharmaceutical businesses are consolidating cause bringing costs down to bring drugs to market is getting exceptionally high," said Davies.

Premium Pick: Volatility Stalls as Traders Ponder What Happens Next

Success Story: Nepal's Only Billionaire Shares His Success Mantra

Subscribe to our Youtube Channel for more videos : Listen our latest Podcasts on Soundcloud

Jim Cramer and TheStreet Launch Bull Market Fantasy Channel on Maven

Jim picks stocks on Wall Street, now he's picking NFL players for fantasy football! Check it out at BullMarketFantasy.com - check it out here or see his latest videos below:

Cramer Confessional: Jim Cramer's One Fantasy Drafting Regret

Cramer's Fantasy Football Draft Got a Little Crazy - Watch

Jim Cramer Breaks Down His Top Lesson From His Fantasy Draft

Catch Up: Today's Top News Videos Below

Related Videos